Literature DB >> 19471118

At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.

Zoya N Demidenko1, Mikhail V Blagosklonny.   

Abstract

Here we demonstrated that, at cytostatic, near-toxic concentrations, resveratrol inhibited S6 phosphorylation and prevented the senescence morphology in human cells. Using a sensitive functional assay, we found that resveratrol partially prevented loss of the proliferative potential associated with cellular senescence. Resveratrol was less effective than rapamycin, because aging-suppression by resveratrol was limited by its toxicity at high concentrations. We discuss whether concentrations of resveratrol that inhibit mTOR (target of rapamycin) and suppress cellular senescence are clinically achievable and whether partial inhibition of mTOR by resveratrol might be sufficient to affect organismal aging.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471118     DOI: 10.4161/cc.8.12.8810

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  60 in total

1.  Interspecies Chemical Signals Released into the Environment May Create Xenohormetic, Hormetic and Cytostatic Selective Forces that Drive the Ecosystemic Evolution of Longevity Regulation Mechanisms.

Authors:  Michelle T Burstein; Adam Beach; Vincent R Richard; Olivia Koupaki; Alejandra Gomez-Perez; Alexander A Goldberg; Pavlo Kyryakov; Simon D Bourque; Anastasia Glebov; Vladimir I Titorenko
Journal:  Dose Response       Date:  2011-07-27       Impact factor: 2.658

2.  Rapamycin induces pluripotent genes associated with avoidance of replicative senescence.

Authors:  Tatiana V Pospelova; Tatiana V Bykova; Svetlana G Zubova; Natalia V Katolikova; Natalia M Yartzeva; Valery A Pospelov
Journal:  Cell Cycle       Date:  2013-12-02       Impact factor: 4.534

3.  Cell size and growth rate are major determinants of replicative lifespan.

Authors:  Jingye Yang; Huzefa Dungrawala; Hui Hua; Arkadi Manukyan; Lesley Abraham; Wesley Lane; Holly Mead; Jill Wright; Brandt L Schneider
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

4.  Inhibition of activated pericentromeric SINE/Alu repeat transcription in senescent human adult stem cells reinstates self-renewal.

Authors:  Jianrong Wang; Glenn J Geesman; Sirkka Liisa Hostikka; Michelle Atallah; Benjamin Blackwell; Elbert Lee; Peter J Cook; Bogdan Pasaniuc; Goli Shariat; Eran Halperin; Marek Dobke; Michael G Rosenfeld; I King Jordan; Victoria V Lunyak
Journal:  Cell Cycle       Date:  2011-09-01       Impact factor: 4.534

5.  The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells.

Authors:  Anya Alayev; Sara Malka Berger; Melissa Y Kramer; Naomi S Schwartz; Marina K Holz
Journal:  J Cell Biochem       Date:  2015-03       Impact factor: 4.429

6.  mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.

Authors:  Kaveh M Goudarzi; Monica Nistér; Mikael S Lindström
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

7.  Inhibition of S6K by resveratrol: in search of the purpose.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2009-06-29       Impact factor: 5.682

Review 8.  Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol.

Authors:  Eugenia Morselli; Lorenzo Galluzzi; Oliver Kepp; Alfredo Criollo; Maria Chiara Maiuri; Nektarios Tavernarakis; Frank Madeo; Guido Kroemer
Journal:  Aging (Albany NY)       Date:  2009-12-23       Impact factor: 5.682

Review 9.  Validation of anti-aging drugs by treating age-related diseases.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2009-03-28       Impact factor: 5.682

10.  SIRT1 negatively regulates the mammalian target of rapamycin.

Authors:  Hiyaa Singhee Ghosh; Michael McBurney; Paul D Robbins
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.